J
James D. Neaton
Researcher at University of Minnesota
Publications - 352
Citations - 68183
James D. Neaton is an academic researcher from University of Minnesota. The author has contributed to research in topics: Risk factor & Blood pressure. The author has an hindex of 101, co-authored 331 publications receiving 64719 citations. Previous affiliations of James D. Neaton include University of Pittsburgh & Medical Research Council.
Papers
More filters
Journal ArticleDOI
Concorde trial of immediate versus deferred zidovudine
Matthias Egger,James D. Neaton,Andrew N. Phillips,George Davey Smith,Neil M.H. Graham,Julio S. G. Montaner,Janet Raboud,Michael V. O'Shaughnessy,Peter A. Laing,Sheila M. Gore,A. Graham Bird,Bernard Hirschel,Aboulker Jp,A Babiker,JH Darbyshire,J Dormont,Tea Peto,M. Seligmann,Ann Marie Swart,I. V. D. Weller +19 more
Journal Article
Insights from monitoring the CPCRA didanosine/zalcitabine trial. Terry Beirn Community Programs for Clinical Research on AIDS.
Thomas R. Fleming,James D. Neaton,Anne I. Goldman,David L. DeMets,Cynthia A. Launer,Joyce A. Korvick,Donald I. Abrams +6 more
TL;DR: In this article, a randomized trial of didanosine and zalcitabine (ddI) was conducted by the Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA).
Journal ArticleDOI
How to construct an optimal interim report: What the data monitoring committee does and doesn't need to know.
TL;DR: The unblinded statisticians responsible for preparing closed data monitoring committee reports should be familiar with the statistical methods, the trial protocol, and the data collection plan and be capable of customizing the report to the current stage of the trial.
Journal ArticleDOI
Earlier initiation of antiretroviral therapy in treatment-naïve patients: implications of results of treatment interruption trials.
James D. Neaton,Birgit Grund +1 more
TL;DR: It is suggested that the use of antiretroviral therapy earlier than recommended by current guidelines warrants investigation and definitive data from randomized studies that are powered to reliably assess risks and benefits are needed to guide when it is initiated.
Journal ArticleDOI
Comparison of the Outcomes of Individuals With Medically Attended Influenza A and B Virus Infections Enrolled in 2 International Cohort Studies Over a 6-Year Period: 2009-2015.
Dominic E. Dwyer,Ruth Lynfield,Marcelo H. Losso,Richard T. Davey,Alessandro Cozzi-Lepri,Deborah Wentworth,Timothy M. Uyeki,Fred M. Gordin,Brian Angus,Tavs Qvist,Sean Emery,Jens D Lundgren,James D. Neaton +12 more
TL;DR: Outpatients infected with influenza A(H1N1)pdm09 or influenza B were more likely to be hospitalized than those with A(h3N2), and hospitalized patients infected with A (H1n1)PDm09 were younger and morelikely to have severe disease at study entry, but did not have worse 60-day outcomes.